Bleeding Risk and Antithrombotic Strategy in Patients with Sinus Rhythm Heart Failure with Reduced Ejection Fraction Treated with Warfarin or Aspirin

We sought to assess the performance of existing bleeding risk scores, such as HAS-BLED or OBRI, in patients with heart failure with reduced ejection fraction (HFrEF) in sinus rhythm (SR) treated with warfarin or aspirin. We calculated HAS-BLED and OBRI risk scores for 2,305 patients with HFrEF in SR...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Am J Cardiol
Egile Nagusiak: Ye, Siqin, Cheng, Bin, Lip, Gregory Y. H., Buchsbaum, Richard, Sacco, Ralph L., Levin, Bruce, Di Tullio, Marco R., Qian, Min, Mann, Douglas L., Pullicino, Patrick M., Freudenberger, Ronald S., Teerlink, John R., Mohr, J.P., Graham, Susan, Labovitz, Arthur J., Estol, Conrado J., Lok, Dirk J., Ponikowski, Piotr, Anker, Stefan D., Thompson, John L.P., Homma, Shunichi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4554775/
https://ncbi.nlm.nih.gov/pubmed/26189039
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2015.06.016
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak